AllianceBernstein International Health Care Portfolio EUR I

Performance (in EUR)

Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.

Performance

1 month -5.89%
Current year -2.58%
3 years p.a. 2.15%
5 years p.a. 5.42%
10 years p.a. 9.45%
Since inception p.a. n.a.

Rolling performance in %

Key figures

YTD 1 year 3 years 5 years 10 years
Performance -2.58% -4.61% 6.59% 30.23% 146.71%
Maximum profit on monthly basis 3.56% 7.22% 7.22% 8.13% 12.73%
Maximum loss on monthly basis -5.89% -6.25% -6.25% -7.56% -8.64%
Max drawdown -8.42% -16.78% -25.19% -25.19% -25.71%
Volatility 15.09% 16.36% 13.37% 13.65% 15.76%
Sharpe ratio -0.91 -0.38 -0.02 0.27 0.55
Maximum continuous profit in months 1 4 5 5 6
Maximum continuous loss in months 1 4 5 5 5
Positive months / profit duration in months 2 6 22 35 75
Negative months / loss duration in months 2 7 15 26 46

Master data

Fund name AllianceBernstein International Health Care Portfolio EUR I
Fund management company AllianceBernstein (Luxembourg) S.à r.l.
Fund domicile Luxembourg
Inception date 24 November 2000
ISIN LU0251855366
Swiss security no. 2599840
Fund currency EUR
Appropriation of income accumulating
Issuing commission
Ongoing charges under PRIIP KID as at 25 February 2026 1.14%
End of financial year 31 May
Paying agent
Fund volume as at 27 February 2026 2.12 Mrd. EUR
Net asset value (NAV) as at 31 March 2026 610.03 EUR

Portfolio structure

Top holdings of fund volume (in %)

Johnson & Johnson 10.30%
Eli Lilly & Co. 9.38%
AstraZeneca, PLC 6.16%
Roche Holdings AG 6.01%
Novartis AG 5.35%
AbbVie, Inc. 4.93%
Gilead Sciences 4.43%
Stryker 3.91%
Unitedhealth Group, Inc. 3.91%
Intuitive Surgical 3.62%

Asset allocation

Currency

Countries

Sectors